Scientists have developed a test that uses cells from a single donor’s blood to predict whether a new drug will cause a severe reaction in humans.
The test could avert disasters like the 2006 trial of the drug TGN1412, which led to six healthy young men being admitted to intensive care with multiple organ failure. The volunteers receiving TGN1412 experienced a catastrophic inflammatory reaction called a cytokine storm.
Cytokine storm reactions are a particular worry for new biological therapies, or “biologics”, which use biological material such as antibodies. Many blockbuster drugs such as the cancer drugs Herceptin and Avastin are biologics, as are around a third of medicines in the pharmaceutical pipeline. Because these medicines are specific to humans, they can cause severe reactions that don’t materialise in animal studies, so tests on human cells are essential.
However, cytokine storm side effects are hard to predict with tests were just one cell type is used, since they depend on interactions between blood cells and endothelial cells, which form the lining of blood vessels. But because endothelial cells are deep within the body, they are normally only grown from tissue removed in surgery or post mortem, or from umbilical vessels after birth.
Because of this, current tests use endothelial cells taken from vessels of one donor, and white blood cells from a different donor. When cells from two different donors are used, one may have an immune reaction to the other, meaning the system is already primed for inflammation before the drug is added. This can result in the test falsely showing a severe immune reaction to a drug that is safe.
Researchers at Imperial College London got around this problem by isolating stem cells from the blood of a volunteer, and using them to grow endothelial cells in a dish. They then took white blood cells which they added to the donor’s own endothelial cells to recreate the unique conditions found in their blood vessels. When TGN1412 was added to the test tube, the mixture of cells released a cytokine storm, as would happen inside the body.
The new method is better as it only requires blood from one donor and doesn’t mix cells from different people, with the advantage of making a more reliable test.
Professor Jane Mitchell, from the National Heart and Lung Institute at Imperial College London, who led the study, said: “As biological therapies become more mainstream, it’s more likely that drugs being tested on humans for the first time will have unexpected and potentially catastrophic effects. We’ve used adult stem cell technology to develop a laboratory test that could prevent another disaster like the TGN1412 trial.
“Drug companies have the technical capacity to start using this test now, but we’re working on developing an off-the-shelf kit which will make it easy to use on a large scale.”
Dr Daniel Reed, the first author on the study, said: ”A further benefit of this new technology is that personalised therapies can be tested to see how safe and effective they will be for an individual.”
The Latest on: Personalised therapies
via Google News
The Latest on: Personalised therapies
Bringing gene therapies to market
on June 17, 2019 at 5:23 am
As our understanding of these diseases has grown in parallel with developments in genome sequencing, so has our understanding of how to potentially treat them using personalised gene therapies. ... […]
Learning about personalised medicine
on June 17, 2019 at 12:03 am
Later on, these mutations which are related to a disease by GWAS studies can be used to diagnose that disease and help the medical practitioner to decide the best personalised therapy. There are ... […]
Personalized Medicine could be Possible by Genetic Technology
on June 14, 2019 at 7:16 am
Personalized medicine is the practice of tailoring disease prevention, diagnosis, and treatment to patients as individuals. Many cancers, for example, are resistant to conventional therapies but ... […]
How occupational therapy can help people live with arthritis
on June 14, 2019 at 1:03 am
For example, the American Occupational Therapy Association said that occupational therapy practitioners may recommend personalized adaptive equipment to patients with arthritis who are experiencing ... […]
First clinical test could enable personalized prognosis for triple-negative breast cancer patients
on June 13, 2019 at 5:24 pm
A personalized prognosis for patients diagnosed with triple ... Those patients will not respond to any of the targeted therapies developed to treat breast cancer with those characteristics. After ... […]
Ambitious new cancer therapies being developed in Wellington
on June 12, 2019 at 3:50 pm
“We expect clinical trials to enable early access to CAR T-cell therapy for New Zealanders, and to establish the local manufacturing capability and regulatory processes needed for these personalised ... […]
Future of mCRC Lies in Biomarker-Directed Therapies
on June 12, 2019 at 11:37 am
has been in the form of biomarker-directed therapy and immunotherapy, said Christopher Lieu, MD. Although these advances have been made in only a small percentage of the overall population, these ... […]
CAR-T Cell Therapy Shows Potential in Relapsed/Refractory Mantle Cell Lymphoma
on June 12, 2019 at 8:11 am
We could use DNA, RNA epigenetic mutation and will the discrete mechanism of resistance of each patient and use what we can according to aim to target these pathways so we can overcome resistance in ... […]
Baxter Launches Sharesource 2.0 Telehealth Platform to Support Greater Clinical Insights and Personalized Peritoneal Dialysis Care
on June 12, 2019 at 4:01 am
This suggests remote patient management can achieve time and cost savings for providers and patients by allowing for a more personalized therapy regime and early detection and resolution of ... […]
mHealth Partnership Adds Music Therapy to Stroke Rehabilitation Toolkit
on June 11, 2019 at 11:33 am
MedRhythms, which began as a therapy program launched out of Partners Healthcare ... targets stress relief and pain reduction as well as rehab. “The combination of personalized, dynamic content with ... […]
via Bing News